US Patent Issued to DSM IP Assets on Jan. 27 for "Microbial strain expressing an invertase/sucrose hydrolase" (Danish Inventor)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,701, issued on Jan. 27, was assigned to DSM IP Assets B.V. (Heerlen, Denmark).

"Microbial strain expressing an invertase/sucrose hydrolase" was invented by Manos Papadakis (Horsholm, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and which is capable of hydrolysing non-phosphorylated sucrose into fructose and glucose.The identification of efficient enzymes capable of hydrolysing sucrose in its non-modified form, a...